Germany: Paul-Ehrlich-Institut [clinicaltrials_resource:1e7c9bcda51397542ecb8e452545f186]
TBP Study With Capecitabine Plus Minus Trastuzumab [clinicaltrials:NCT00148876]clinicaltrials:NCT00191724clinicaltrials:NCT00274742Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU) [clinicaltrials:NCT00290836]clinicaltrials:NCT00304265clinicaltrials:NCT00372177Efficacy and Safety of Grazax in Children [clinicaltrials:NCT00408616]clinicaltrials:NCT00440401clinicaltrials:NCT00464893Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb [clinicaltrials:NCT00500786]clinicaltrials:NCT00509184clinicaltrials:NCT00536640Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy [clinicaltrials:NCT00540150]clinicaltrials:NCT00560313clinicaltrials:NCT00560794Nimotuzumab in Children With Intrinsic Pontine Glioma [clinicaltrials:NCT00561691]Nimotuzumab in Adults With Pancreatic Cancer [clinicaltrials:NCT00561990]Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer [clinicaltrials:NCT00563836]clinicaltrials:NCT00567554Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) [clinicaltrials:NCT00617760]Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [clinicaltrials:NCT00635596]clinicaltrials:NCT00644059Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT) [clinicaltrials:NCT00655343]Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens [clinicaltrials:NCT00666341]Safety of Cat-PAD in Cat Allergic Subjects [clinicaltrials:NCT00685711]clinicaltrials:NCT00712101Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders [clinicaltrials:NCT00718627]clinicaltrials:NCT00725231clinicaltrials:NCT00750971Nimotuzumab in Adults With Glioblastoma Multiforma [clinicaltrials:NCT00753246]clinicaltrials:NCT00791141clinicaltrials:NCT00822809Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease [clinicaltrials:NCT00831467]clinicaltrials:NCT00836641Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [clinicaltrials:NCT00857779]High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT [clinicaltrials:NCT00858793]Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47 [clinicaltrials:NCT00873431]Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients [clinicaltrials:NCT00876252]clinicaltrials:NCT00894569The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis [clinicaltrials:NCT00904254]
oversight [clinicaltrials_vocabulary:oversight]
Germany: Paul-Ehrlich-Institut [clinicaltrials_resource:1e7c9bcda51397542ecb8e452545f186]
Bio2RDF identifier
1e7c9bcda51397542ecb8e452545f186
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1e7c9bcda51397542ecb8e452545f186
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:1e7c9bcda51397542ecb8e452545f186
title
Germany: Paul-Ehrlich-Institut
@en
type
label
Germany: Paul-Ehrlich-Institut [clinicaltrials_resource:1e7c9bcda51397542ecb8e452545f186]
@en